472 Comparing the Effects of Systemic and Intrathecal Etanercept–Methylprednisolone Therapies Within Experimental Spinal Cord Injury

View at publisher Summarise with VIRAT
Authors: Lucas Gorial Garmo, Sid Osborn, Emily Hock, Jonathan Hughes, Elise Darragh, Grace Tavi, David Doyle, Julien Rossignol, Gary Leo Dunbar
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Despite growing knowledge of spinal cord injury (SCI) pathophysiology, treatments for the permanent functional deficits resulting from SCI remain scarce. Methylprednisolone (MP), despite demonstrating mixed clinical efficacy in the management of acute SCI, has shown promise in reducing neuroinflammation and promoting functional recovery in recent animal studies. Etanercept (ETN), a tumor necrosis factor (TNF) inhibitor, has recently gained special attention in SCI discourse due to its potential neuroprotective effects following SCI. METHODS: Forty-eight Wistar rats underwent T9 clip-compression SCI and randomized to one of eight treatment groups (n = 6 / group) of either systemic saline, systemic MP, systemic ETN, systemic MP + ETN, intrathecal saline, intrathecal MP, intrathecal ETN, or intrathecal MP + ETN. Treatments were administered 30 minutes after SCI. Locomotor function was evaluated pre-injury, 3-days post-injury, and weekly thereafter for six weeks using the Basso, Beattie, Bresnahan locomotor rating scale (BBB). Blinded researchers scored each video-recorded session using the standardized BBB scale, with higher BBB scores indicating greater motor function. RESULTS: On interim analysis, repeated-measures ANOVA of BBB scores revealed a significant interaction between injection type and treatment allocation over time. Thus far, intrathecal MP seemed to significantly reduce average BBB scores as compared to intrathecal saline, whereas intrathecal ETN demonstrated noninferiority to intrathecal saline. Rats receiving intrathecal ETN seemed to demonstrate significantly greater BBB scores than rats receiving intrathecal MP. CONCLUSIONS: This study is the first to compare systemic and intrathecal ETN, MP, and their combination in a rat SCI model. Preliminary findings suggest that intrathecal MP may hinder the functional recovery of rats following SCI. Ongoing analyses of treatment effects on histopathological and biochemical alterations following SCI will provide a more holistic assessment.

Fields of Study & Subjects

Spinal Cord Injury Research Veterinary Orthopedics and Neurology Nerve injury and regeneration

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
138–138
Publication date
26 March 2026
Language
EN